Compass Therapeutics CMPX
NASDAQ CMPX
$1.10 -0.01 (-1.36%)
As of: Sep 29, 2026 · 3:59 PM EDT

Compass Therapeutics (CMPX) Total Debt (2018 - 2021)

Updated

Compass Therapeutics' Total Debt came in at $3.74 million for Q3 2021.

Analysis

Compass Therapeutics (CMPX) Total Debt (2018 - 2021) Analysis & Trends

At the end of FY2020, Compass Therapeutics' Total Debt was $9.33 million, down 37.6% from FY2019.

  • Going back by year, Total Debt was $14.96 million in FY2019 and $34,525 in FY2018.
  • The Q3 2021 figure represents the lowest quarterly Total Debt since Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Compass Therapeutics 199.90 Mn 199.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 3.74 Mn
Mar 31, 2021 7.47 Mn
Dec 31, 2020 9.33 Mn
Sep 30, 2020 11.19 Mn
Jun 30, 2020 13.04 Mn
Mar 31, 2020 103,110.00
Dec 31, 2019 14.96 Mn
Sep 30, 2019 85,610.00
Jun 30, 2019 72,125.00
Mar 31, 2019 72,125.00
Dec 31, 2018 62,125.00
Sep 30, 2018 49,625.00
Jun 30, 2018 49,625.00
Mar 31, 2018 34,525.00
API Access

Compass Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=CMPX&period=max&api_key=YOUR_API_KEY